Invicorp

Phentolamine mesilate and aviptadil, the active ingredients in Invicorp, are vasodilators presented as a sterile solution for intracavernous use. It treats erectile dysfunction by enhancing penile blood flow in adult males.

GNH USA supplies Invicorp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Invicorp is indicated for conditions affecting penile vascular function and erectile capacity.

Erectile dysfunction: improves erection quality by increasing blood flow to the corpus cavernosum. Vasculogenic erectile dysfunction: restores smooth‑muscle relaxation in penile tissue. Refractory erectile dysfunction: offers an alternative when oral PDE5 inhibitors are ineffective.

Adverse reactions may occur with intracavernous administration.

Common Side Effects: - Penile pain or discomfort - Local bruising or hematoma at injection site - Transient headache - Flushing or warmth sensation - Mild hypotension - Nausea

Serious or Rare Side Effects: - Priapism lasting longer than four hours - Severe hypotension leading to dizziness or syncope - Allergic reaction with rash, itching, or swelling - Vascular injury or fibrosis at injection site

Use Invicorp only under medical supervision and after confirming diagnosis.

Allergy assessment: verify no known hypersensitivity to phentolamine, aviptadil, or formulation excipients. Cardiovascular evaluation: avoid in patients with uncontrolled hypertension or recent myocardial infarction. Concurrent vasodilators: monitor for additive blood pressure effects. Pregnancy and lactation: contraindicated unless benefits outweigh risks. Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potential drug interactions should be reviewed before therapy.

Major Interactions (Avoid): - Nitrates: combined use may cause profound hypotension. - Alpha‑blockers: additive vasodilatory effect leading to severe blood pressure drop.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may require dose adjustment. - PDE5 inhibitors: monitor for excessive penile erection. - Monoamine oxidase inhibitors: watch for blood pressure fluctuations.